Skip to main content
. 2021 Mar 5;13(3):197–209. doi: 10.1093/jmcb/mjab014

Figure 1.

Figure 1

CD8+ T cells, CD4+ T cells, B cells, and CD3−HLA-DR− lymphocytes in peripheral blood from the HDCR cohorts. (A) Gating strategies used for CD8+ T cells (CD3+CD4−CD8+), CD4+ T cells (CD3+CD8−CD4+), B cells (CD3−CD19−HLA-DR+), and CD3−HLA-DR− lymphocytes (CD3−HLA-DR−) in PBMCs. (B) Frequencies of CD8+ T cells, CD4+ T cells, B cells, and CD3−HLA-DR− lymphocytes among total lymphocytes in the HD and CR cohorts. Data on the CD8+ T cells, CD4+ T cells, and CD3−HLA-DR− lymphocytes were obtained from 55 healthy donors and 55 COVID-19 recovered individuals. Data on the B cells were obtained from 55 healthy donors and 36 COVID-19 recovered individuals. ns, nonsignificant; *P < 0.05.